AzTrials
AzTrials

Digital Nerve InjuryNCT07904286

Sensory Neurography and S2PD After Digital Nerve Injury

An observational study of Digital Nerve Injury and Sensory Neurography, run by Cecilia Mellstrand Navarro at 2 sites in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical comparative cross sectional study, is to investigate neurophysiological findings and S2PD (static two point discrimination test) measurements after digital nerve injury. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Digital Nerve Injury, Sensory Neurography, S2PD
What is being tested?
Sensory neurography and Static two point discrimination test, S2PD
How many people
60 participants
Where
2 sitesSweden
Study dates
28 Sep 2026to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Patients treated surgically for a digital nerve injury at the Sodersjukhuset Hand Surgery Clinic from 2013 to 2023.

Who may be able to join

  • Injury: One year or more prior to inclusion
  • Injured finger: digit II, III or radial dig IV
  • Level of injury: base or middle phalanx
  • Age at injury>20
  • Age at inclusion<60

Who cannot join

  • Neurologic disease
  • Dementia
  • Cognitive disability
  • Severe psychiatric disorder (not be able to participate)
  • Ongoing drug abuse
  • Not understanding swedish language
  • History of carpal tunnel syndrome
  • Negative experience of electric stimulation

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Sweden2 sites, 2 recruiting
  • Karolinska Institutet Södersjukhuset, Department of clinical research and education

    Stockholm, 11883

    Not yet recruiting
  • South General Hospital

    Stockholm, 11883

    Carin Carlsson, MD, 004681236000, carin.carlsson@regionstockholm.se

    Recruiting

Other trials in Sweden

About this study

Official title: Investigation of the Correlation of Sensory Neurography Findings and S2PD Measurements After Digital Nerve Injury

The goal of this clinical comparative cross sectional study, is to investigate neurophysiological findings and S2PD (static two point discrimination test) measurements after digital nerve injury.

The main aim is to find out if there are measurable neurophysiological differences in fingers following digital nerve injury that correlate with discriminative sensory function (S2PD) as experienced by the patient. Secondary aim is to investigate how well neurophysiological measurements predict specific S2PD values in the affected fingers.

Read more

Participants with a sutured digital nerve injury will be examined with neurophysiology and S2PD testing. Both injured finger and corresponding uninjured finger on the other hand will be examined, i.e participants will be their own control.

Prior to the study the investigators will perform a test-re-test study on ten participants to ensure that the method is reliable (separate registration)

Read the detailed description

The aim of this project is to use neurophysiological assessment to gain a better understanding of what is actually measured by S2PD (static two-point discrimination). A neurophysiological examination can objectively measure any remaining function in an injured digital nerve. Using this method, axons responsible for pressure, vibration, and touch that are still able to conduct an action potential, are assessed.

The response can be measured both as the amplitude of the summed action potentials from the nerve's axons and as the area, which corresponds to the area under the curve formed by the recorded action potentials. The area is a somewhat more precise measurement method, as it includes all axons, both those with low and high conduction velocities. Amplitude measurements may give falsely low values if nerves with poorer degrees of myelination are included in the measurement. Amplitude is measured in µV and area in µV/ms.

The method currently used to assess discriminative sensation, S2PD, is influenced by many external factors, such as the clinician's level of experience, the patient's desire to give the correct answer, language barriers, and similar issues. Furthermore, this examination method does not clarify what is actually being measured beyond the patient's subjective discriminative sensation.

If neurophysiological assessment is used as a complement to S2PD and can provide an objective measurement tool with high reliability and reproducibility, it could become an important addition to the clinical arsenal for follow-up after nerve injury. Such knowledge would make it easier to clinically evaluate, understand, and monitor the healing process of the injured nerve. It would also facilitate the assessment and systematic follow-up of treatment outcomes.

The investigators also believe that patients would benefit from being able to follow nerve healing in a more objective manner, which could help motivate continued training and rehabilitation (such as tactile stimulation, mirror therapy, desensitization, etc.).

Participants will be identified through the national quality register for hand surgery (HAKIR), and will be invited to attend an examination at the Hand Surgery Outpatient Clinic at Sodersjukhuset by phone (postal invitation if no response). If the response rate is low, patients will be contacted by phone one additional time.

The visit, which is estimated to last approximately 60 minutes, will include assessment using static two-point discrimination (S2PD) and neurophysiological examination of the injured finger as well as the corresponding finger on the contralateral, uninjured hand. Sensory assessment with S2PD will be performed on the fingertip pulp, radially or ulnarly, using a discriminator. Sensory thresholds, measured in millimetres, will be recorded in the study protocol.

Finger temperature will be measured using an infrared thermometer (Testo 826-T2), and, if necessary, the fingers will be warmed (using a water bath or heating pad) to a target temperature of a minimum of 32 °C. The hands will then be gently abraded using a preparation gel (NuPrep). Conductive gel (Ten20) will be applied to the electrodes.

A recording electrode will be placed volarly over the wrist, a ground electrode in the palm, and a stimulating electrode on the finger (digits II, III, or IV). Electrical stimulation will be delivered in an orthodromic direction, from the finger toward the wrist. The stimulus intensity will be gradually increased as long as the recorded amplitude continues to rise, up to a maximum of 20% above the intensity at which no further increase in amplitude is observed. This approach ensures inclusion of all excitable axons in the recording, regardless of individual firing thresholds.

Being tested
Sensory neurography, Static two point discrimination test, S2PD
Keywords
S2PD, Sensory nerve action potential, Neurophysiology, Static two-point discrimination test, Digital nerve injury, Sensory neurography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sensory neurographyDiagnostic test

    Participants will be examined with sensory neurography (orthodromic stimulation).

  • Static two point discrimination test, S2PDDiagnostic test

    Participants will be examined with S2PD.

Study groups in NCT07904286
Study groupRoleWhat they receive
Sensory and neurophysiology outcome in injured digitThe finger with an injured digital nerve will be examined with S2PD and sensory neurography
Receives: Diagnostic Test: Sensory neurography; Diagnostic Test: Static two point discrimination test, S2PD
Sensory and neurophysiology outcome in normal digitThe contralateral uninjured finger will be examined with S2PD and sensory neurography
Receives: Diagnostic Test: Sensory neurography; Diagnostic Test: Static two point discrimination test, S2PD

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Is there a correlation between the amplitude of the sensory nerve action potential and S2PD?

    A potential correlation between the sensory nerve action potential amplitude (microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

  2. Is there a correlation between sensory nerve action potential area and S2PD?

    A potential correlation between the sensory nerve action potential area (milliseconds*microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

Secondary outcomes (7)
  1. Does a certain value of S2PD correspond to a specific (percentage) value of the amplitude or area of the action potential?

    We will evaluate the correlation between S2PD (in 1 mm steps) and the percentages of sensory neurography amplitude and area of the injured nerve.

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

  2. How does age affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?

    A regression analysis will be used to evaluate what impact age (years) has on primary outcomes.

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

  3. How does participants' sex affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?

    A regression analysis will be used to evaluate what impact participants' sex (male or female) has on primary outcomes.

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

  4. How does smoking affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?

    A regression analysis will be used to evaluate what impact smoking (yes or no) has on primary outcomes.

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

  5. How does the type of injured nerve affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?

    A regression analysis will be used to evaluate what impact type of injured nerve (digital nerves to second, third or radial side of the fourth finger) has on primary outcomes.

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

  6. How does time from injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?

    A regression analysis will be used to evaluate what impact time from injury (in years) has on primary outcomes.

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

  7. How does the level of injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?

    A regression analysis will be used to evaluate what impact level of injury (proximal or middle phalanx) has on primary outcomes.

    Measured: Participant assessments will be conducted during a single session lasting approximately 60 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study start28 Sep 2026
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07904286
Sponsor's protocol ID
2023-05732-01
Other IDs
2023
Status last verified
Oct 2026
First submitted
9 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data will be available in pseudonymized form

Publications

  • https://doi.org/10.1016/S1531-0914(03)00069-X

  • Zanette G, Lauriola MF, Tamburin S. An electrodiagnostic technique for assessing palmar proper digital nerves of the hand: Normative data and clinical application. Muscle Nerve. 2015 Dec;52(6):972-80. doi: 10.1002/mus.24668. Epub 2015 Sep 15.

    PubMed 25845854
  • Lundborg G, Rosen B. The two-point discrimination test--time for a re-appraisal? J Hand Surg Br. 2004 Oct;29(5):418-22. doi: 10.1016/j.jhsb.2004.02.008.

    PubMed 15336741
  • Wolny T, Linek P. Reliability of two-point discrimination test in carpal tunnel syndrome patients. Physiother Theory Pract. 2019 Apr;35(4):348-354. doi: 10.1080/09593985.2018.1443358. Epub 2018 Feb 26.

    PubMed 29482409

Questions about this trial

What is this clinical trial studying?

An observational study of Digital Nerve Injury and Sensory Neurography, run by Cecilia Mellstrand Navarro at 2 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Carin Carlsson, MD (0046812361000, carin.carlsson@regionstockholm.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Is there a correlation between the amplitude of the sensory nerve action potential and S2PD? (time frame: Participant assessments will be conducted during a single session lasting approximately 60 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07904286, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in